Joe Taylor
Psychiatric/Mental Health · Hammond, LANPI 1851347215
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $31,700 of the $38,018 with a category attached, or 83.4%. AbbVie accounts for 90.1% of it on its own, with 24 other manufacturers making up the rest. Among psychiatric/mental health clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 316 payments — averaging $120.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$34K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$577
- Alkermes, Inc.$360
- Vanda Pharmaceuticals Inc.$354
- AstraZeneca$338
- Neurocrine Biosciences, Inc.$301
- plus $2K from 19 others
What the payments were for
- Speaking & faculty fees$31,70083%
- Travel & lodging$7122%
- Food & beverage$5,52315%
- Education$830%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 147 | $34,255 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 29 | $577 |
| Alkermes, Inc. | 14 | $360 |
| Vanda Pharmaceuticals Inc. | 14 | $354 |
| AstraZeneca | 8 | $338 |
| Neurocrine Biosciences, Inc. | 16 | $301 |
| Teva Pharmaceuticals USA, Inc. | 14 | $290 |
| Johnson & Johnson | 11 | $208 |
| Otsuka America Pharmaceutical, Inc. | 8 | $202 |
| Indivior Inc. | 8 | $163 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $158 |
| Lundbeck LLC | 9 | $155 |
| Supernus Pharmaceuticals, Inc. | 4 | $129 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Corium, LLC | 4 | $80 |
| Axsome Therapeutics, Inc. | 3 | $80 |
| Sunovion Pharmaceuticals Inc. | 4 | $65 |
| Lilly USA, LLC | 3 | $54 |
| CSL Behring | 1 | $23 |
| Jazz Pharmaceuticals Inc. | 1 | $22 |
| Philips North America LLC | 1 | $20 |
| Scilex Pharmaceuticals Inc. | 1 | $18 |
| Boston Scientific | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Ironshore Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$38,018 in reported general payments places this provider in the 95th percentile of 615 psychiatric/mental health providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 43 | $62,436 |
| RexultiBrexpiprazole | 11 | $18,670 |
| LinzessLinaclotide | 13 | $9,164 |
| TrintellixVortioxetine Hydrobromide | 15 | $6,970 |
| GemtesaVibegron | 12 | $5,131 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 83 | $1,991 |
| Dexlansoprazole DrDexlansoprazole | 13 | $1,771 |
| Quetiapine Fumarate | 103 | $1,265 |
| Duloxetine Hcl | 147 | $1,220 |
| Gabapentin | 115 | $1,161 |
| Trazodone Hcl | 113 | $1,152 |
| Buspirone Hcl | 124 | $1,064 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 20 | $1,039 |
| Bupropion XlBupropion Hcl | 84 | $871 |
| Fluvoxamine Maleate | 21 | $729 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar, Linzess | $34,255 | $71,60056 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $202 | $18,67011 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $158 | $6,97015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 615 psychiatric/mental health providers in Louisiana.
Other psychiatric/mental health in Hammond
- Amy LacoutureBaton Rouge$663K
- Amanda EymardHouma$617K
- Amber LittlefieldBroussard$225K
- Timothy PellegrinHouma$210K
- Melissa GuilbeauLafayette$122K
- Kimberly ForcinelShreveport$92K
- Sattaria DilksLake Charles$57K
- Lecy AlbaradoScott$34K
- Michelle DyerLake Charles$33K
- Shantell BurnsPrairieville$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.